Effects of Trp64Arg mutation in the β3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients

Diabetes Care

Volumn 20, Issue 12, 1997, Pages 1887-1890

  Sakane, Naoki ^a,b   Yoshida, Toshihide ^a   Umekawa, Tsunekazu ^a   Kogure, Akinori ^a   Takakura, Yasuto ^a   Kondo, Motoharu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Ayabe Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ALLELE; ARTICLE; BODY FAT; DIABETES CONTROL; DRUG EFFECT; FEMALE; FOOD INTAKE; GENE MUTATION; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0030731084     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.12.1887     Document Type: Article

References (36)

1. Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D: Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 147:1749-1753, 1987
2. Wing RR, Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH: Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 151:1334-1340, 1991
3. Hughes TA, Gwyne JT, Switzer BR, Herbst C, White G: Effects of caloric restriction and weight loss on glycemic control, insulin release and insulin resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus. Am J Med 77:7-17, 1984
4. 3-adrenergic receptor mRNA in man. J Clin Invest 91:344-349, 1993
5. 3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 289:223-228, 1995
6. 3-adrenoceptors in obesity. J Clin Invest 95:1109-1116, 1995
7. 3-adrenoceptor in man. J Clin Invest 95:2239-2245, 1995
8. 3-adrenergic receptor gene. N Engl J Med 333:343-347, 1995
9. 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351,1995
10. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352-354, 1995
11. 3-adrenergic receptor gene and response to treatment of obesity. Lancet 346:1433-1434, 1995
12. 3-adrenergic receptor gene on weight loss after a low calorie diet (Abstract). Int J Obes 20 (Suppl. 4):124, 1996
13. 3-adrenoceptor genes in obese people submitted to a low calorie diet. Int J Obesity 20:1051-1054, 1996
14. 3-adrenergic receptor with NIDDM and body weight gain. Diabetologia 39:349-352, 1996
15. 3-adrenergic receptor gene with NIDDM, current and maximal body mass index (Letter). Diabetologia 39:1410, 1996
16. Durnin JVGA, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurement of 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-97, 1974
17. Tanaka K, Kato H, Kikuchi K, Nagatomo M, Nakajimi H, Shibayama H, Ebashi H, Nishijima Y, Matsuzawa M, Ogawa S: Anthropometric and body composition characteristics of shindeshi sumo wrestlers (in Japanese). J Phys Fitness Jpn 28:257-264, 1979
18. Yoshida T, Sakane N, Umekawa T, Kondo M: Relationship between basal metabolic rate, thermogenic response to caffeine, and body weight loss following combined low calorie and exercise treatment in obese women. Int J Obesity 18:345-350, 1994
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
20. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H: A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care 19:1138-1141, 1996
21. Duncan MH, Singh BM, Eise PH, Carter G, Allaghband-Zadeh JA: A simple measure of insulin resistance in human disease. Lancet 346:120-121, 1995
22. 3-adrenergic receptor polymorphism: a genetic marker for visceral fat obesity and insulin resistance syndrome. Diabetologia 40:200-204, 1997
23. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 215: 555-560, 1995
24. 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39:857-860, 1996
25. 3-adrenergic receptor gene. Diabetes 45:1115-1120, 1996
26. 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women: effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 45:1358-1363, 1996
27. 3-adrenergic receptor gene in Nauruans with obesity and non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:4155-4158, 1996
28. 3-adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes 46:77-80, 1997
29. 3-adrenergic receptor gene. Endocrinology 270:29483-29492, 1995
30. 3-adrenoceptor sensitivity in visceral adipose tissue. Diobetologia 39:838-844, 1996
31. 3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care 271-272, 1996
32. 3-adrenergic receptor mutant. Endocrinology 137:2638-2641, 1996
33. 3-adrenoceptor gene of doubtful significance for obesity and insulin resistance. Lancet 348:698-699, 1996
34. 3-adrenoceptor gene variant in obesity and insulin resistance. Lancet 348:1584-1585, 1996
35. 3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake: a study using transgenic and gene knockout mice. J Biol Chem 272:17686-17693, 1997
36. 3-adrenergic agonist, SR 58611 (Abstract). Endocrinology 986, 1996